Clinical Trial Update: PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer [Phase 1]

View source ↗

Summary

This document reports an ongoing Phase 1 clinical trial by the University of California, Davis evaluating PLZ4-coated paclitaxel-loaded micelles for recurrent o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• PLZ4-coated paclitaxel-loaded micelles (paclitaxel-loaded micelles with PLZ4 coating)

Snippet

Sponsor: University of California, Davis | Conditions: Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8 | Phase 1 | Status: RECRUITING